IN8bio (INAB) Balance Sheet: Assets & Liabilities

IN8bio (INAB) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), IN8bio reported total assets of $32.28M and total liabilities of $4.72M. Shareholders' equity was $27.56M, up 90.3% from $14.48M a year earlier. Total debt stood at $2.78M against $27.09M in cash and short-term investments, a net cash position of $24.31M. That puts debt-to-equity at 0.10, compared with 0.35 a year earlier.

IN8bio Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for IN8bio, Inc. (INAB) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	27.09	11.12	21.28	18.18	37.02	17.99	0.61	4.99
Cash & Short-Term Investments	27.09	11.12	21.28	18.18	37.02	17.99	0.61	4.99
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.03
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.02
Other Current Assets	0.79	1.46	3.34	4.05	1.96	0.15	0.15	0.05
Total Current Assets	27.88	12.58	24.63	22.23	38.98	18.14	0.76	5.07
Non-Current Assets
Property, Plant & Equipment (Net)	4.04	7.83	8.57	10.30	2.83	0.19	0.27	0.80
Long-Term Investments	0.22	0.27	0.26	0.25	0.00	0.00	0.00	0.00
Intangible Assets	0.00	0.00	0.00	0.13	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.15	0.28	0.51	0.38	0.41	2.58	0.09	0.03
Total Non-Current Assets	4.40	8.37	9.08	10.81	3.24	2.77	0.37	0.82
Total Assets	32.28	20.94	33.71	33.04	42.22	20.91	1.13	5.90
Current Liabilities
Accounts Payable	0.31	0.39	0.92	2.09	0.40	0.62	0.56	0.42
Short-Term Debt	1.22	1.65	1.51	1.39	0.63	0.17	0.00	0.00
Current Portion of Long-Term Debt	-	-	-	-	-	0.17	-	-
Accrued Liabilities	1.63	0.84	2.96	0.88	1.24	0.90	-	-
Other Current Liabilities	1.63	1.05	2.96	2.34	1.24	1.78	0.09	0.00
Total Current Liabilities	3.16	3.08	5.39	5.82	2.26	2.57	0.65	0.42
Non-Current Liabilities
Long-Term Debt	1.56	3.38	3.38	4.49	1.78	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.02	0.83	0.83
Total Non-Current Liabilities	1.56	3.38	3.38	4.49	1.78	0.02	0.83	0.83
Total Liabilities	4.72	6.47	8.77	10.31	4.04	2.59	1.48	1.25
Stockholders' Equity
Common Stock	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-141.10	-121.66	-91.22	-61.21	-32.69	-18.04	-9.48	-4.35
Additional Paid-in Capital	168.64	136.13	116.15	83.94	70.87	1.46	0.24	0.10
Shares Outstanding	9.77	2.42	1.44	0.82	0.63	-	-	-
Total Stockholders' Equity	27.56	14.48	24.94	22.73	38.18	18.32	-0.35	4.65
Total Liabilities & Equity	32.28	20.94	33.71	33.04	42.22	20.91	1.13	5.90

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About IN8bio Balance Sheet

How much debt does IN8bio have?

IN8bio had total debt of $2.78M as of Dec 31, 2025, against $27.09M in cash and short-term investments. Its debt-to-equity ratio was 0.10. Total debt was $5.03M a year earlier.

What are IN8bio's total assets?

IN8bio reported total assets of $32.28M as of Dec 31, 2025, up 54.1% from $20.94M a year earlier. Total liabilities were $4.72M.

What is IN8bio's shareholders' equity?

IN8bio's shareholders' equity was $27.56M as of Dec 31, 2025, or about $2.82 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition